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STUDIUM PRZYPADKU / CLINICAL VIGNETTE
Optical coherence tomography to reveal  
vascular lesions after catheter-based renal 
nerve ablation with a novel multi-electrode  
EnligHTNTM system
Optyczna tomografia koherencyjna ujawniająca uszkodzenie naczynia  
po przezcewnikowej denerwacji tętnic nerkowych z zastosowaniem  
nowego systemu wieloelektrodowego EnligHTNTM
Milosz Jaguszewski, Jelena-Rima Ghadri, Thomas F. Lüscher, Christian Templin
Cardiovascular Centre Cardiology, University Hospital of Zurich, Zurich, Switzerland
A 72-year-old female with a history of sleep apnoea syndrome was referred to the Andreas Gruentzig Catheterisation 
Laboratories for catheter-based renal nerve ablation (RNA) due to drug-resistant, uncontrolled hypertension. After in-
travenously loading with aspirin, the RNA was obtained using the first generation multi-electrode EnligHTNTM system  
(St. Jude Medical, Westford, MA, USA) delivering 8 ablation runs on both the left and the right renal artery. Before 
and after the RNA procedure, optical coherence tomography (OCT) was performed using the C7-XR imaging system 
(LightLab Imaging, Inc., Westford, MA, USA) with a non-occlusive technique and a single-mode optical fibre catheter 
(frequency domain-OCT-catheter, DragonFlyTM, St. Jude Medical, Westford, MA, USA). The OCT catheter was advanced 
over a standard 0.014’’ angioplasty guidewire using a monorail lumen at the tip. To optimise pullback recordings, renal 
arteries were flashed of blood with Ultravist 300 (Bayer House, Berkshire, United Kingdom) at a flow rate of 8.0 mL/s 
and the application of an automated pullback speed of 20 mm/s. The post-procedural pullback visualised local oedemas  
(Fig. 1A, B) concomitant with significant thrombi formations (Fig. 1A, C) and small disruptions (Fig. 1D, arrow). The clini-
cal course was uneventful and the patient was discharged home on the second day of hospitalisation. 
Catheter-based RNA has been recently approved for the treatment of resistant hypertension. During the RNA procedure, 
transmural lesions are delivered along the walls of the renal arteries to disrupt the sympathetic nerve network located 
within the arterial adventitia.
Here, we report a case in which OCT was 
performed to reveal potential periproce-
dural vascular side effects. The RNA was 
obtained using a novel EnligHTNTM cath-
eter delivering a basket with 4 radiopaque 
electrodes (Fig. 1E, inset). The design of the 
EnligHTNTM system enabled simultaneous 
ablation runs, minimising catheter ma-
nipulation (Fig. 1E, arrows). However, the 
performance of OCT revealed several local 
lesions including post-ablation oedemas, 
thrombi formations and tissue disruptions. 
OCT provides novel insights on vascular 
effects of RNA, suggesting the potential 
need for double antiplatelet therapy before 
the procedure. However, the safety and 
efficacy of the new catheter-based RNA 
devices require soon to be evaluated in 
greater detail. 
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Figure 1. Optical coherence tomography (cross-sections and pullback) to reve-
al local acute morphological vascular changes after catheter-based RNA such 
as thrombus formations (A, C), vessel notches (B, E) and dissections (D)
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